Mackenzie Financial
EW icon

Mackenzie Financial’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.74M Sell
60,647
-9,670
-14% -$756K 0.01% 612
2025
Q1
$5.1M Sell
70,317
-59,528
-46% -$4.31M 0.01% 577
2024
Q4
$9.61M Buy
129,845
+23,729
+22% +$1.76M 0.01% 474
2024
Q3
$7M Buy
106,116
+14,626
+16% +$965K 0.01% 496
2024
Q2
$8.45M Sell
91,490
-4,014
-4% -$371K 0.01% 465
2024
Q1
$9.13M Buy
95,504
+3,422
+4% +$327K 0.01% 460
2023
Q4
$7.02M Sell
92,082
-67,034
-42% -$5.11M 0.01% 491
2023
Q3
$11.1M Buy
159,116
+19,208
+14% +$1.34M 0.02% 415
2023
Q2
$12.8M Sell
139,908
-500,463
-78% -$45.8M 0.02% 409
2023
Q1
$53M Buy
640,371
+3,803
+0.6% +$315K 0.08% 215
2022
Q4
$47.5M Sell
636,568
-76,905
-11% -$5.74M 0.08% 210
2022
Q3
$59M Buy
713,473
+24,438
+4% +$2.02M 0.1% 188
2022
Q2
$65.5M Buy
689,035
+33,468
+5% +$3.18M 0.1% 186
2022
Q1
$77.2M Buy
655,567
+19,798
+3% +$2.33M 0.1% 186
2021
Q4
$82.4M Buy
635,769
+125,610
+25% +$16.3M 0.11% 185
2021
Q3
$57.8M Buy
510,159
+13,874
+3% +$1.57M 0.08% 216
2021
Q2
$51.4M Buy
496,285
+223,316
+82% +$23.1M 0.07% 221
2021
Q1
$22.8M Buy
272,969
+209,696
+331% +$17.5M 0.03% 295
2020
Q4
$5.77M Buy
63,273
+6,984
+12% +$637K 0.01% 420
2020
Q3
$4.49M Sell
56,289
-17,406
-24% -$1.39M 0.01% 416
2020
Q2
$5.09M Buy
73,695
+35,183
+91% +$2.43M 0.01% 394
2020
Q1
$7.26M Buy
38,512
+26,211
+213% +$4.94M 0.02% 304
2019
Q4
$2.87M Buy
12,301
+10,052
+447% +$2.35M 0.01% 548
2019
Q3
$495K Buy
2,249
+622
+38% +$137K ﹤0.01% 822
2019
Q2
$301K Sell
1,627
-475
-23% -$87.9K ﹤0.01% 956
2019
Q1
$402K Sell
2,102
-4,021
-66% -$769K ﹤0.01% 1058
2018
Q4
$938K Sell
6,123
-3,812
-38% -$584K ﹤0.01% 819
2018
Q3
$1.73M Buy
9,935
+1,435
+17% +$250K ﹤0.01% 675
2018
Q2
$1.24M Buy
8,500
+757
+10% +$110K ﹤0.01% 653
2018
Q1
$1.08M Buy
7,743
+2,057
+36% +$287K ﹤0.01% 632
2017
Q4
$641K Buy
5,686
+1,329
+31% +$150K ﹤0.01% 654
2017
Q3
$476K Buy
4,357
+426
+11% +$46.5K ﹤0.01% 522
2017
Q2
$465K Buy
3,931
+1,195
+44% +$141K ﹤0.01% 524
2017
Q1
$257K Buy
2,736
+198
+8% +$18.6K ﹤0.01% 580
2016
Q4
$238K Buy
+2,538
New +$238K ﹤0.01% 582
2016
Q3
Sell
-8,166
Closed -$814K 720
2016
Q2
$814K Buy
8,166
+466
+6% +$46.5K ﹤0.01% 649
2016
Q1
$679K Sell
7,700
-21,900
-74% -$1.93M 0.01% 595
2015
Q4
$2.34M Buy
29,600
+22,900
+342% +$1.81M 0.01% 386
2015
Q3
$953K Buy
6,700
+3,533
+112% +$503K 0.01% 545
2015
Q2
$451K Buy
3,167
+493
+18% +$70.2K ﹤0.01% 687
2015
Q1
$381K Buy
+2,674
New +$381K ﹤0.01% 697
2014
Q4
Sell
-621,900
Closed -$63.5M 735
2014
Q3
$63.5M Sell
621,900
-118,700
-16% -$12.1M 0.32% 70
2014
Q2
$63.6M Sell
740,600
-277,900
-27% -$23.9M 0.3% 79
2014
Q1
$75.5M Buy
1,018,500
+161,200
+19% +$12M 0.37% 63
2013
Q4
$56.4M Buy
857,300
+269,300
+46% +$17.7M 0.28% 74
2013
Q3
$40.9M Buy
588,000
+576,300
+4,926% +$40.1M 0.21% 114
2013
Q2
$786K Buy
+11,700
New +$786K ﹤0.01% 524